Second Transplantation for Relapsed Hematologic Malignancies After First Allogeneic Hematopoietic Stem Cell Transplantation From an HLA-Matched Related Donor.
Second transplantation offers a potential path forward for patients who relapse after their first stem cell transplant, addressing a major clinical challenge.
Relapse after allogeneic hematopoietic stem cell transplantation (allo-HCT) from human leukocyte antigen (HLA)-matched related donors (MRDs) remains a major clinical challenge. The record is retained for conservative triage based on its relevance and observational cohort study.
What the study was
- Study design
- Observational cohort study
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Transplant Cell Ther
Why it surfaced
Retained as a observational cohort study relevant to Hematologic malignancies; scoring is conservative from PubMed metadata and abstract only.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.